Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Clin Nutr. 2021 May;40(5):3314-3324. doi: 10.1016/j.clnu.2020.10.058. Epub 2020 Nov 7.
We assessed the association of Mediterranean diet with NAFLD and their interaction in predicting ten-year diabetes onset and first fatal/non-fatal cardiovascular disease (CVD) incidence.
The ATTICA prospective observational study in Athens, Greece included 1,514 men and 1,528 women (>18 years old) free-of-CVD at baseline. Liver steatosis and fibrosis indices were calculated. Mediterranean diet adherence was assessed through MedDietScore. At the ten-year follow-up visit, CVD evaluation was performed in an a priori specified subgroup of n = 2,020 participants and diabetes onset in n = 1,485 free-of-diabetes participants.
MedDietScore was inversely associated with steatosis and fibrosis; e.g. in the case of the TyG index the Odds Ratio (OR) of the 3rd vs. 1st MedDietScore tertile was = 0·53, [95% Confidence Interval (95% CI) (0·29, 0·95)] and the associations persisted in multi-adjusted models. NAFLD predicted incident diabetes prospectively over a ten year period [HR = 1·87, 95% CI (0·75, 4·61)] and the association remained significant only in subjects with low MedDietScore (below median) whereas diabetes onset among subjects with higher MedDietScore was not influenced by NAFLD. Similarly, NAFLD predicted CVD [Hazard Ratio (HR) = 3·01, 95%CI(2·28, 3·95)]; the effect remained significant only in subjects with MedDietScore below median [HR = 1·38, 95% CI (1·00, 1·93)] whereas it was essentially null [HR = 1·00,95% CI (0·38, 2·63)] among subjects with higher score. Mediation analysis revealed that adiponectin and adiponectin-to-leptin ratio were the strongest mediators.
We report an inverse association between Mediterranean diet and NAFLD. Mediterranean diet protected against diabetes and CVD prospectively among subjects with NAFLD.
我们评估了地中海饮食与非酒精性脂肪性肝病(NAFLD)之间的关联及其在预测十年糖尿病发病和首次致命/非致命心血管疾病(CVD)发生率方面的相互作用。
希腊雅典的 ATTICA 前瞻性观察研究纳入了 1514 名男性和 1528 名女性(年龄>18 岁),基线时无 CVD。计算肝脂肪变性和纤维化指数。通过 MedDietScore 评估地中海饮食的依从性。在十年随访时,在预先指定的 n=2020 名参与者亚组中进行 CVD 评估,并在 n=1485 名无糖尿病参与者中评估糖尿病发病情况。
MedDietScore 与脂肪变性和纤维化呈负相关;例如,在 TyG 指数的情况下,第 3 与第 1 个 MedDietScore 三分位数的比值比(OR)为 0.53 [95%置信区间(95%CI)(0.29,0.95)],且关联在多调整模型中仍然存在。NAFLD 在十年期间前瞻性地预测了糖尿病的发生[风险比(HR)=1.87,95%CI(0.75,4.61)],并且这种关联仅在 MedDietScore 较低(中位数以下)的受试者中仍然显著,而在 MedDietScore 较高的受试者中,NAFLD 对糖尿病发病没有影响。同样,NAFLD 预测 CVD [风险比(HR)=3.01,95%CI(2.28,3.95)];这种效应仅在 MedDietScore 中位数以下的受试者中仍然显著[HR=1.38,95%CI(1.00,1.93)],而在 MedDietScore 较高的受试者中,这种效应基本为零[HR=1.00,95%CI(0.38,2.63)]。中介分析显示,脂联素和脂联素与瘦素的比值是最强的中介物。
我们报告了地中海饮食与 NAFLD 之间的负相关。地中海饮食在有 NAFLD 的受试者中对糖尿病和 CVD 具有前瞻性的保护作用。